Pharma

Verve Therapeutics: Q4 Earnings Snapshot

By
AP News
We may earn a commission from links on this page.

BOSTON (AP) — BOSTON (AP) — Verve Therapeutics Inc. (VERV) on Tuesday reported a loss of $48.4 million in its fourth quarter.

Suggested Reading

Jerry Seinfeld's Porsche — driven by Steve McQueen — is going up for auction
Intel stock pops 8% because someone apparently wants to buy the troubled chipmaker
Walgreens' digital doors looked cool — but ended up a $200 million disaster
Jamie Dimon warned of economic threats as his bank posted its biggest annual profit ever
Subtitles
  • Off
  • English

The Boston-based company said it had a loss of 69 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 80 cents per share.

Suggested Reading

Jerry Seinfeld's Porsche — driven by Steve McQueen — is going up for auction
Intel stock pops 8% because someone apparently wants to buy the troubled chipmaker
Walgreens' digital doors looked cool — but ended up a $200 million disaster
Jamie Dimon warned of economic threats as his bank posted its biggest annual profit ever
Subtitles
  • Off
  • English

Related Content

Vanguard will pay $106 million over 'misleading statements' about retirement funds
SpaceX ordered to investigate after its Starship spewed debris over Turks and Caicos

The biotechnology firm posted revenue of $5.1 million in the period.

For the year, the company reported a loss of $200.1 million, or $3.12 per share. Revenue was reported as $11.8 million.

Advertisement

Related Content

Vanguard will pay $106 million over 'misleading statements' about retirement funds
SpaceX ordered to investigate after its Starship spewed debris over Turks and Caicos

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VERV at https://www.zacks.com/ap/VERV

Advertisement